Roche Diagnostics Division
This article was originally published in The Gray Sheet
Executive Summary
Boehringer Mannheim Chairman Otto Meile, who also is responsible for all Roche activities in Germany, succeeds Jean-Luc Belingard as head of the unit Oct. 1 and assumes a spot on the Roche executive committee. Belingard, who joined Roche in 1982 and was picked to lead the diagnostics operation in 1990, is returning to France from Basel "for family reasons, where he intends to pursue activities" outside of Roche, the company says
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.